Aramark Q1 2026 Earnings Recap

Aramark delivered robust first quarter results for fiscal 2026, with organic revenue growth of 5% to $4.8 billion, strengthened by exceptional client retention and significant new business wins.

Key Takeaways

• FSS US organic revenue grew to $3.4 billion (2%), with anticipated recovery from calendar shifts expected in Q2.
• International sales surged over 13% year-over-year, marking the nineteenth consecutive quarter of double-digit growth.
• Key contract wins include the largest healthcare contract in US history with Penn Medicine and a major agreement with RWJBarnabas Health in New Jersey.
• The company is well-positioned to achieve a net new business growth target of 4% to 5% for fiscal 2026, bolstered by high retention rates and accelerated onboarding of new accounts.
• Strong performance in the global supply chain indicates effective cost management and client service optimization amid ongoing inflationary trends.